CLC bio rolls out NGS data analysis plug-in; FDA plans expansion of social media monitoring;

> Qiagen's ($QGEN) CLC bio has released a plug-in to accelerate analysis of NGS data. Release

> The FDA is considering expanding its social media monitoring activities. Article

> Genomics startup ActX has raised $1.9 million in a seed round. News

> UC Santa Cruz has added childhood cancer data to its genomics hub. Piece

> Quest Diagnostics ($DGX) is expanding its use of Illumina ($ILMN) sequencing technology. Item

Suggested Articles

There's no evidence personal patient information leaked during the 11-week breach, but the same can't be said about Sangamo's own secrets.

Through a new online tracker, AllTrials names sponsors who fail to report clinical trial results on time per the FDAAA Final Rule.

The new solution aims to streamline the incorporation of human genomic data into clinical trial designs.